Business Description
Optimind Pharma Corp
NAICS : 325412
SIC : 3741
ISIN : CA68405U1012
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.14 | |||||
Debt-to-Equity | 4.97 | |||||
Debt-to-EBITDA | -0.22 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | -17.96 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
9-Day RSI | 38.14 | |||||
14-Day RSI | 37.88 | |||||
6-1 Month Momentum % | -80 | |||||
12-1 Month Momentum % | -80 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.27 | |||||
Quick Ratio | 0.27 | |||||
Cash Ratio | 0.05 | |||||
Days Sales Outstanding | 85.17 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -7.2 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -561.59 | |||||
Net Margin % | -1938.41 | |||||
FCF Margin % | -453.62 | |||||
ROE % | -268.41 | |||||
ROA % | -158.7 | |||||
ROIC % | -46.28 | |||||
ROC (Joel Greenblatt) % | -2705.88 | |||||
ROCE % | -222.41 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.5 | |||||
PB Ratio | 5 | |||||
EV-to-EBIT | -0.4 | |||||
EV-to-EBITDA | -0.4 | |||||
EV-to-Revenue | 7.46 | |||||
EV-to-FCF | -1.65 | |||||
Earnings Yield (Greenblatt) % | -250 | |||||
FCF Yield % | -127.76 |